Owners, management and financials
CVR: 40666699
DKK -13,192,351
Gross profit
Net result: DKK -22,366,605
Eli Lilly and Company (10-14,99%), Lindhardt Holdings ApS (5-9,99%)
4 more
CVR · view owners
Karsten Lindhardt
Board: John Michael Barberich (chair) and 5 members
CVR · view management
Active
Founded 17 July 2019
CVR · view overview
20 employees
Annual report 2025 · average
Owner registered: HTGF Opportunity GmbH & Co. KG
CVR · 20/08/2026
View the full event history
Biograil ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Karsten Lindhardt. The board consists of John Michael Barberich (chair), Karsten Lindhardt, Lars Hellerung Christiansen and Robert Samuel. The company's owners include Eli Lilly and Company, Lindhardt Holdings ApS and High-Tech Gründer-fonds III GmbH & Co. KG. According to the 2025 annual report, the company had an average of 20 employees. In 2025, the company reported a gross profit of DKK -13,192,351 and a net result of DKK -22,366,605 compared with DKK -17,084,308 the year before. Equity in the 2025 report amounted to DKK 102,217,548.
Selskabets formål er udvikle avancerede medicinske produkter samt al virksomhed, som efter ledelsens skøn har forbindelse hermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -13.2 mio. | -22.4 mio. | 108.8 mio. | 102.2 mio. | 20 | |
| 202401/01/2024 – 31/12/2024 | 4.8 mio. | -17.1 mio. | 75.1 mio. | 18.8 mio. | 18 | |
| 202301/01/2023 – 31/12/2023 | -16.7 mio. | -34.8 mio. | 76.2 mio. | 10 mio. | 14 | |
| 202201/01/2022 – 31/12/2022 | 26.3 mio. | 12.9 mio. | 95.3 mio. | 44.8 mio. | 6 | |
| 202101/01/2021 – 31/12/2021 | -5.4 mio. | -7.9 mio. | 33.1 mio. | 31.9 mio. | 3 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Biograil ApS is 40666699.
The owners of Biograil ApS include Eli Lilly and Company, Lindhardt Holdings ApS and High-Tech Gründer-fonds III GmbH & Co. KG.
The management of Biograil ApS consists of Karsten Lindhardt.
The board of Biograil ApS consists of John Michael Barberich, Karsten Lindhardt and Lars Hellerung Christiansen, with John Michael Barberich as chair.
In 2025, Biograil ApS reported a gross profit of DKK -13,192,351.
Biograil ApS had an average of 20 employees in the 2025 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
As of August 20, 2026, is registered as an owner of Biograil ApS with an ownership share of 5%.
As of August 20, 2026, is registered as an owner of Biograil ApS with an ownership share of 15%.
Biograil ApS has published its annual report for 2025. Gross profit came to DKK -13,192,351, and the net result was DKK -22,366,605.
As of December 15, 2025, Robert Samuel has joined the board of directors of Biograil ApS.
As of December 15, 2025, Ulrik Schulze has joined the board of directors of Biograil ApS.
As of December 15, 2025, is registered as an owner of Biograil ApS with an ownership share of 10%.
As of December 15, 2025, Lindhardt Holdings ApS is registered as an owner of Biograil ApS with an ownership share of 5%.
As of December 15, 2025, MTI Biograil Invest A/S is registered as an owner of Biograil ApS with an ownership share of 15%.
As of June 30, 2025, Karsten Lindhardt has joined the board of directors of Biograil ApS.
As of June 30, 2025, Steffen Wagner has joined the board of directors of Biograil ApS.
As of June 30, 2025, Anke Cassing has left the board of directors of Biograil ApS.
As of June 23, 2025, is registered as an owner of Biograil ApS with an ownership share of 5%.
Biograil ApS has published its annual report for 2024. Gross profit came to DKK 4,816,978, and the net result was DKK -17,084,308.
Biograil ApS has published its annual report for 2023. Gross profit came to DKK -16,707,823, and the net result was DKK -34,799,433.
Biograil ApS has published its annual report for 2022. Gross profit came to DKK 26,317,577, and the net result was DKK 12,876,552.
Biograil ApS has published its annual report for 2021. Gross profit came to DKK -5,373,412, and the net result was DKK -7,932,078.
Biograil ApS has published its interim report for the period July 17, 2019 – December 31, 2020.
As of October 12, 2020, Karsten Lindhardt has left the board of directors of Biograil ApS.
As of December 31, 2019, Anke Cassing has joined the board of directors of Biograil ApS.
As of November 10, 2019, Lars Hellerung Christiansen has joined the board of directors of Biograil ApS.
As of November 10, 2019, Karsten Lindhardt has joined the board of directors of Biograil ApS.
As of November 10, 2019, John Michael Barberich has joined the board of directors of Biograil ApS.
As of July 17, 2019, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Biograil ApS.
As of July 17, 2019, Karsten Lindhardt is registered as director of Biograil ApS.
Biograil ApS was founded on July 17, 2019.
Companies in the same industry and area
CVR 26110262
CVR 32304362
CVR 37456136
CVR 38179845
CVR 38434969
